| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Cox Troy serves as a Director at LAB and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $1.9M at current prices.
The biggest single holding is SOPH (~$1.8M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | MPLT Maplight Therapeutics, Inc. | Director | Buy | 15,620 | $9.52 | $148,702.40 | New | - | - |